Microbiome-targeting treatment is set to evolve, address multiple immunological indications: GlobalData Read more
Sales of long-acting immunosuppressants for non-infectious uveitis to touch $357 mn by 2029: GlobalData Read more
Opportunities remain to address unmet needs in cystic fibrosis therapeutics market: GlobalData Read more
Patient access to gene therapies for cancer likely to increase in the next decade: GlobalData Read more